---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-092003"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2026-08-06T20:11:13+00:00"
generated_at: "2026-08-06T20:15:16.113383+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Astrana Health Q2 revenue $972.5M (+49% YoY); raises 2026 adjusted EBITDA guidance

## Summary
- Q2 revenue $972.5M (+49% YoY); net income attributable $19.7M (+109%); adjusted EBITDA $68.9M (+43%).
- Adjusted diluted EPS $0.80 (+45% YoY); six-month adjusted EPS $1.54 (+59%).
- Six-month free cash flow $92.9M; operating cash flow $100.8M.
- Management raises 2026 adjusted EBITDA guidance citing strong first-half outperformance.
- Care Partners revenue $932.8M (+48% YoY) drives top-line growth.

## SEC filing metadata
- accession: 0001104659-26-092003
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2026-08-06T20:11:13+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465926092003/0001104659-26-092003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465926092003/tm2622348d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-092003
- JSON: https://secwatch.observer/filing/0001104659-26-092003.json
- Plain text: https://secwatch.observer/filing/0001104659-26-092003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.